RELATION OF MICROALBUMINURIA AND CORONARY ARTERY DISEASE IN NON DIABETIC PATIENTS

被引:0
作者
Hoseini, Vida Nesar [1 ]
Taziki, Omolbanin [1 ]
机构
[1] FatemeZahra Hosp, Artesh Blvd, Sari, Mazandaran, Iran
关键词
Coronary artery disease; diabetes; microalbuminuria;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
INTRODUCTION: Prospective studies confirmed that microalbuminuria is a predictor of cardiovascular diseases, independent of classical risk factors and is associated with all-cause mortality in patients with diabetes or hypertension and in the general population. However, there is few data linking angiographic severity of coronary artery disease (CAD) to microalbuninuria (MA). We examined coronary angiograms for extent of severe CAD (luminal narrowing 50%) in patients without Diabetes Mellitus (DM) and general population. METHODS: Our study comprised of 153 patients undergoing coronary angiography in Hazrat Fatemeh hospital in Iran (M/F 80/73, mean age 57 +/- 11 y). Urine albumin excretion was measured in 24h urine samples by immune precipitation technique. Age-sex, distribution of coronary risk factors and MA were compared between patients with and without CAD. RESULTS: Overall, 70.5% (108) of patients had CAD and 29.4% (45) had no coronary lesion. MA was detected in 62.9% of patients with CAD and 8.8% of those without coronary artery lesion (P < 0.05). The presence of 1 or 2 vessels CAD showed a linear increase from group to group without microalbuminuria (P < 0.05). CONCLUSION: Patients with MA have more severe angiographic CAD compared to those without MA. This relation is independent of other risk factors.
引用
收藏
页码:13 / 16
页数:4
相关论文
共 24 条
[1]   Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria [J].
Asselbergs, FW ;
Diercks, GFH ;
Hillege, HL ;
van Boven, AJ ;
Janssen, WMT ;
Voors, AA ;
de Zeeuw, D ;
de Jong, PE ;
van Veldhuisen, DJ ;
van Gilst, WH .
CIRCULATION, 2004, 110 (18) :2809-2816
[2]   Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension [J].
Bigazzi, R ;
Bianchi, S ;
Baldari, D ;
Campese, VM .
JOURNAL OF HYPERTENSION, 1998, 16 (09) :1325-1333
[3]  
Clausen P, 2001, CIRCULATION, V103, P1869
[4]   Proteinuria and other markers of chronic kidney disease: A position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [J].
Eknoyan, G ;
Hostetter, T ;
Bakris, GL ;
Hebert, L ;
Levey, AS ;
Parving, HH ;
Steffes, MW ;
Toto, R .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (04) :617-622
[5]   Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects:: The Insulin Resistance Atherosclerosis Study [J].
Festa, A ;
D'Agostino, R ;
Howard, G ;
Mykkänen, L ;
Tracy, RP ;
Haffner, SM .
KIDNEY INTERNATIONAL, 2000, 58 (04) :1703-1710
[6]   Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals [J].
Gerstein, HC ;
Mann, JFE ;
Yi, QL ;
Zinman, B ;
Dinneen, SF ;
Hoogwerf, B ;
Hallé, JP ;
Young, J ;
Rashkow, A ;
Joyce, C ;
Nawaz, S ;
Yusuf, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (04) :421-426
[7]   Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population [J].
Hillege, HL ;
Fidler, V ;
Diercks, GFH ;
van Gilst, WH ;
de Zeeuw, D ;
van Veldhuisen, DJ ;
Gans, ROB ;
Janssen, WMT ;
Grobbee, DE ;
de Jong, PE .
CIRCULATION, 2002, 106 (14) :1777-1782
[8]   Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy?: A LIFE substudy [J].
Ibsen, H ;
Wachtell, K ;
Olsen, MH ;
Borch-Johnsen, K ;
Lindholm, LH ;
Mogensen, CE ;
Dahlöf, B ;
Devereux, RB ;
de Faire, U ;
Fyhrquist, F ;
Julius, S ;
Kjeldsen, SE ;
Lederballe-Pedersen, O ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wan, Y .
JOURNAL OF HYPERTENSION, 2004, 22 (09) :1805-1811
[9]   Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients -: Losartan intervention for endpoint reduction in hypertension study [J].
Ibsen, H ;
Olsen, MH ;
Wachtell, K ;
Borch-Johnsen, K ;
Lindholm, LH ;
Mogensen, CE ;
Dahlöf, B ;
Devereux, RB ;
de Faire, U ;
Fyhrquist, F ;
Julius, S ;
Kjeldsen, SE ;
Lederballe-Pedersen, O ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wan, Y .
HYPERTENSION, 2005, 45 (02) :198-202
[10]   Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes [J].
Klausen, K ;
Borch-Johnsen, K ;
Feldt-Rasmussen, B ;
Jensen, G ;
Clausen, P ;
Scharling, H ;
Appleyard, M ;
Jensen, JS .
CIRCULATION, 2004, 110 (01) :32-35